10.01.2015 Views

Here - Stiftung Forschung 3R

Here - Stiftung Forschung 3R

Here - Stiftung Forschung 3R

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Respiratory Skin Controls<br />

Protease 1 *<br />

Protease 2 *<br />

Chemicals – Pre/Prohaptens<br />

Proteins (N = 1)<br />

(N = 4)<br />

Protease 3 * Isoeugenol (Iso) Human serum albumin<br />

(HSA)<br />

Protease 4 *<br />

Eugenol (Eug)<br />

Protease 5 *<br />

Cinnamic alcohol (CA)<br />

Protease 6 *<br />

Paraphenylenediamine<br />

(PPD)<br />

Xylanase 1 *<br />

Xyloglucanase 1 *<br />

considered.<br />

Exclusion criteria included the following:<br />

• Gases and highly volatile chemicals<br />

• Insoluble chemicals<br />

• Metals<br />

• High molecular weight chemicals.<br />

With regard to reference data sources for<br />

the chemicals selection, two sources were<br />

mainly taken into consideration: the LLNA<br />

database (Gerberick GF et al., 2005) and<br />

the European Centre for Ecotoxicology<br />

and Toxicology of Chemicals Technical<br />

report N o .77 (ECETOC; 1999) and N o .87<br />

(ECETOC; 2003). [Complete references<br />

not supplied]<br />

2. Proteins<br />

The selection of the proteins to be used<br />

for the development of the tests has<br />

been performed according to predefined<br />

criteria.<br />

Inclusion criteria included the following:<br />

1) Proteins should be backed by the<br />

availability of high quality in vivo data.<br />

2) Proteins should be readily available.<br />

3) Proteins should cover a relevant range<br />

of protein classes.<br />

Reference data sources: Protein selection<br />

was based upon historical human and<br />

animal data from Novozymes AS (industrial<br />

enzymes) and the Allergome Platform for<br />

Allergen Knowledge (allergome.org).<br />

Toolbox<br />

The Sens-it-iv toolbox is the major<br />

deliverable of the project and its ultimate<br />

legacy after its official termination on<br />

31 March 2011. It contains those assays<br />

developed within the Sens-it-iv project,<br />

or the Sens-it-iv sphere with contribution<br />

of Sens-it-iv, which the consortium found<br />

to be worthy of the search for financial<br />

support beyond the end of the project.<br />

In contrast to the LLNA, these in vitro<br />

tests are usually exclusive for skin or<br />

PROGRESS REPORTS FROM EU-FUNDED PROJECTS<br />

Progress Report 2011 & AXLR8-2 Workshop Report<br />

165

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!